Drug Shortage Report for TEVA-CHLOROQUINE
| Report ID | 99447 |
| Drug Identification Number | 00021261 |
| Brand name | TEVA-CHLOROQUINE |
| Common or Proper name | CHLOROQUINE 250MG TABLETS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CHLOROQUINE DIPHOSPHATE |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | P01BA |
| ATC description | ANTIMALARIALS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2019-11-21 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2020-07-10 |
| Company comments | Need to source and validate an alternate API Supplier |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-07-10 | French | Compare |
| v4 | 2020-07-10 | English | Compare |
| v3 | 2019-11-22 | English | Compare |
| v2 | 2019-11-21 | French | Compare |
| v1 | 2019-11-21 | English | Compare |
Showing 1 to 5 of 5